Press Room

Webinar Series: Amorphous Solid Dispersions by Spray Drying: From Early Formulation to Commercial Lifecycle Management

Start
Tuesday, February 28, 2023 - 16:00
End
Thursday, April 20, 2023 - 17:00
Location: online
Webinar Series Spray Drying - SEM image of a particle in a dark green background

Hovione presents a new comprehensive three-part webinar series on "Amorphous Solid Dispersions by Spray Drying: From Early Formulation to Commercial Lifecycle Management" starting February 28, 2023.



Over the course of this series, Hovione experts will guide you through the complete journey of amorphous solid dispersions (ASDs), starting from the early formulation stage to process development and scale-up, and finally to commercial reality and lifecycle management of ASDs. 

As an experienced manufacturer of ASDs by spray drying for the pharmaceutical industry, Hovione will be able to share its extensive knowledge and experience. Furthermore, the featured experts will be available to answer your questions during a live Q&A.

 

Key Learnings for the Webinar Series

  • Gain knowledge on designing a successful formulation for Amorphous Solid Dispersions produced by Spray Drying
  • Discover how to develop a robust process at lab scale and assure a successful scale-up
  • Learn how to use a model-based methodology to establish the design space and a commercial process
  • Understand what to consider during the Lifecycle Management of a commercial Amorphous Solid Dispersion by Spray Drying 

 

SESSION 1 (On-demand)

Evaluating the Best Formulations for Amorphous Solid Dispersions by Spray Drying

Register Now to join us | Hovione

 

SESSION 2 (On-demand)

ASDs by Spray Drying: Process Development & Scale-Up

Register Now to join us | Hovione

 

SESSION 3 (On-demand)

Commercial Reality and Lifecycle Management of ASDs

Register Now to join us | Hovione

 

 

Do you have a challenging project?

get in touch with us click here | Hovione

Schedule your individual meeting at the upcoming tradeshows and conferences in Berlin, Boston, Orlando, Barcelona, Delhi or Edinburgh.

 

 

 

Also in the Press Room

See All

Integrated approach simplifies development, reduces risk, and supports scalable manufacturing. Hovione and Industrial Design Consultancy Ltd.’s (IDC) lead single-use nasal dry powder device is now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to leverage existing capsule filling infrastructure. This approach simplifies development, reduces cost and risk, and helps shorten timelines to the clinic and commercialization. “This milestone marks an important step in the evolution of our collaboration with IDC — from device innovation to a fully integrated intranasal drug delivery platform,” said Márcio Temtem, Ph.D., Vice President, Strategic Business Management, Hovione. “As the industry looks for faster, more reliable ways to bring complex therapies to patients, integration becomes critical. By bringing together nasal particle engineering science, formulation manufacturing and filling, and device technologies into a single offering, we enable a more seamless and predictable development journey, accelerating the path to market for intranasal therapies.” The nasal delivery device enables broad and targeted nasal deposition flexibility while delivering maximum usability and reliability. With a patented design and manufacturing process established, the platform is available for partnering with pharmaceutical companies on an exclusive basis as part of Hovione’s integrated offering for inhalation and nasal drug development and manufacturing. Additionally, IDC’s Managing Director, Stephen Knowles Ph.D., said the companies are now “well-advanced” with the development of a multi-use device to support an even wider range of therapies and patient needs. Read the full article at ContractPharma.com    

Press Clipping

Hovione, IDC Launch Intranasal Drug Delivery Platform

May 07, 2026